
GMP Cell Banking Industry Research Report 2025
Description
Summary
According to APO Research, The global GMP Cell Banking market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for GMP Cell Banking is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for GMP Cell Banking is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for GMP Cell Banking is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of GMP Cell Banking include Thermo Fisher, Merck KGaA, Lonza, Wuxi Apptec, Texcell, SGS Life Sciences, Sartorius, ProBi and Precision for Medicine, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for GMP Cell Banking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Cell Banking.
The GMP Cell Banking market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GMP Cell Banking market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
GMP Cell Banking Segment by Company
Thermo Fisher
Merck KGaA
Lonza
Wuxi Apptec
Texcell
SGS Life Sciences
Sartorius
ProBi
Precision for Medicine
Kryosphere
Goodwin Biotechnology
Eurofins Scientific
Charles River
Catalent
GMP Cell Banking Segment by Type
Mammalian Cell
Insect Cell
Microbial Cell
Others
GMP Cell Banking Segment by Application
Biopharmaceutical Companies
Contract Manufacturing Organizations
GMP Cell Banking Segment by Application
Biopharmaceutical Companies
Contract Manufacturing Organizations
GMP Cell Banking Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Cell Banking market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Cell Banking and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Cell Banking.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of GMP Cell Banking companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
According to APO Research, The global GMP Cell Banking market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for GMP Cell Banking is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for GMP Cell Banking is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for GMP Cell Banking is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of GMP Cell Banking include Thermo Fisher, Merck KGaA, Lonza, Wuxi Apptec, Texcell, SGS Life Sciences, Sartorius, ProBi and Precision for Medicine, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for GMP Cell Banking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Cell Banking.
The GMP Cell Banking market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GMP Cell Banking market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
GMP Cell Banking Segment by Company
Thermo Fisher
Merck KGaA
Lonza
Wuxi Apptec
Texcell
SGS Life Sciences
Sartorius
ProBi
Precision for Medicine
Kryosphere
Goodwin Biotechnology
Eurofins Scientific
Charles River
Catalent
GMP Cell Banking Segment by Type
Mammalian Cell
Insect Cell
Microbial Cell
Others
GMP Cell Banking Segment by Application
Biopharmaceutical Companies
Contract Manufacturing Organizations
GMP Cell Banking Segment by Application
Biopharmaceutical Companies
Contract Manufacturing Organizations
GMP Cell Banking Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Cell Banking market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Cell Banking and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Cell Banking.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of GMP Cell Banking companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Table of Contents
123 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 GMP Cell Banking by Type
- 2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
- 2.2.2 Mammalian Cell
- 2.2.3 Insect Cell
- 2.2.4 Microbial Cell
- 2.2.5 Others
- 2.3 GMP Cell Banking by Application
- 2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.3.2 Biopharmaceutical Companies
- 2.3.3 Contract Manufacturing Organizations
- 2.4 Assumptions and Limitations
- 3 GMP Cell Banking Breakdown Data by Type
- 3.1 Global GMP Cell Banking Historic Market Size by Type (2020-2025)
- 3.2 Global GMP Cell Banking Forecasted Market Size by Type (2026-2031)
- 4 GMP Cell Banking Breakdown Data by Application
- 4.1 Global GMP Cell Banking Historic Market Size by Application (2020-2025)
- 4.2 Global GMP Cell Banking Forecasted Market Size by Application (2026-2031)
- 5 Global Growth Trends
- 5.1 Global GMP Cell Banking Market Perspective (2020-2031)
- 5.2 Global GMP Cell Banking Growth Trends by Region
- 5.2.1 Global GMP Cell Banking Market Size by Region: 2020 VS 2024 VS 2031
- 5.2.2 GMP Cell Banking Historic Market Size by Region (2020-2025)
- 5.2.3 GMP Cell Banking Forecasted Market Size by Region (2026-2031)
- 5.3 GMP Cell Banking Market Dynamics
- 5.3.1 GMP Cell Banking Industry Trends
- 5.3.2 GMP Cell Banking Market Drivers
- 5.3.3 GMP Cell Banking Market Challenges
- 5.3.4 GMP Cell Banking Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top GMP Cell Banking Players by Revenue
- 6.1.1 Global Top GMP Cell Banking Players by Revenue (2020-2025)
- 6.1.2 Global GMP Cell Banking Revenue Market Share by Players (2020-2025)
- 6.2 Global GMP Cell Banking Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of GMP Cell Banking Head Office and Area Served
- 6.4 Global GMP Cell Banking Players, Product Type & Application
- 6.5 Global GMP Cell Banking Manufacturers Established Date
- 6.6 Global GMP Cell Banking Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America GMP Cell Banking Market Size (2020-2031)
- 7.2 North America GMP Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 7.3 North America GMP Cell Banking Market Size by Country (2020-2025)
- 7.4 North America GMP Cell Banking Market Size by Country (2026-2031)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
- 8 Europe
- 8.1 Europe GMP Cell Banking Market Size (2020-2031)
- 8.2 Europe GMP Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 8.3 Europe GMP Cell Banking Market Size by Country (2020-2025)
- 8.4 Europe GMP Cell Banking Market Size by Country (2026-2031)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific GMP Cell Banking Market Size (2020-2031)
- 9.2 Asia-Pacific GMP Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 9.3 Asia-Pacific GMP Cell Banking Market Size by Country (2020-2025)
- 9.4 Asia-Pacific GMP Cell Banking Market Size by Country (2026-2031)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
- 10 South America
- 10.1 South America GMP Cell Banking Market Size (2020-2031)
- 10.2 South America GMP Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 10.3 South America GMP Cell Banking Market Size by Country (2020-2025)
- 10.4 South America GMP Cell Banking Market Size by Country (2026-2031)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
- 11 Middle East & Africa
- 11.1 Middle East & Africa GMP Cell Banking Market Size (2020-2031)
- 11.2 Middle East & Africa GMP Cell Banking Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 11.3 Middle East & Africa GMP Cell Banking Market Size by Country (2020-2025)
- 11.4 Middle East & Africa GMP Cell Banking Market Size by Country (2026-2031)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
- 12 Players Profiled
- 12.1 Thermo Fisher
- 12.1.1 Thermo Fisher Company Information
- 12.1.2 Thermo Fisher Business Overview
- 12.1.3 Thermo Fisher Revenue in GMP Cell Banking Business (2020-2025)
- 12.1.4 Thermo Fisher GMP Cell Banking Product Portfolio
- 12.1.5 Thermo Fisher Recent Developments
- 12.2 Merck KGaA
- 12.2.1 Merck KGaA Company Information
- 12.2.2 Merck KGaA Business Overview
- 12.2.3 Merck KGaA Revenue in GMP Cell Banking Business (2020-2025)
- 12.2.4 Merck KGaA GMP Cell Banking Product Portfolio
- 12.2.5 Merck KGaA Recent Developments
- 12.3 Lonza
- 12.3.1 Lonza Company Information
- 12.3.2 Lonza Business Overview
- 12.3.3 Lonza Revenue in GMP Cell Banking Business (2020-2025)
- 12.3.4 Lonza GMP Cell Banking Product Portfolio
- 12.3.5 Lonza Recent Developments
- 12.4 Wuxi Apptec
- 12.4.1 Wuxi Apptec Company Information
- 12.4.2 Wuxi Apptec Business Overview
- 12.4.3 Wuxi Apptec Revenue in GMP Cell Banking Business (2020-2025)
- 12.4.4 Wuxi Apptec GMP Cell Banking Product Portfolio
- 12.4.5 Wuxi Apptec Recent Developments
- 12.5 Texcell
- 12.5.1 Texcell Company Information
- 12.5.2 Texcell Business Overview
- 12.5.3 Texcell Revenue in GMP Cell Banking Business (2020-2025)
- 12.5.4 Texcell GMP Cell Banking Product Portfolio
- 12.5.5 Texcell Recent Developments
- 12.6 SGS Life Sciences
- 12.6.1 SGS Life Sciences Company Information
- 12.6.2 SGS Life Sciences Business Overview
- 12.6.3 SGS Life Sciences Revenue in GMP Cell Banking Business (2020-2025)
- 12.6.4 SGS Life Sciences GMP Cell Banking Product Portfolio
- 12.6.5 SGS Life Sciences Recent Developments
- 12.7 Sartorius
- 12.7.1 Sartorius Company Information
- 12.7.2 Sartorius Business Overview
- 12.7.3 Sartorius Revenue in GMP Cell Banking Business (2020-2025)
- 12.7.4 Sartorius GMP Cell Banking Product Portfolio
- 12.7.5 Sartorius Recent Developments
- 12.8 ProBi
- 12.8.1 ProBi Company Information
- 12.8.2 ProBi Business Overview
- 12.8.3 ProBi Revenue in GMP Cell Banking Business (2020-2025)
- 12.8.4 ProBi GMP Cell Banking Product Portfolio
- 12.8.5 ProBi Recent Developments
- 12.9 Precision for Medicine
- 12.9.1 Precision for Medicine Company Information
- 12.9.2 Precision for Medicine Business Overview
- 12.9.3 Precision for Medicine Revenue in GMP Cell Banking Business (2020-2025)
- 12.9.4 Precision for Medicine GMP Cell Banking Product Portfolio
- 12.9.5 Precision for Medicine Recent Developments
- 12.10 Kryosphere
- 12.10.1 Kryosphere Company Information
- 12.10.2 Kryosphere Business Overview
- 12.10.3 Kryosphere Revenue in GMP Cell Banking Business (2020-2025)
- 12.10.4 Kryosphere GMP Cell Banking Product Portfolio
- 12.10.5 Kryosphere Recent Developments
- 12.11 Goodwin Biotechnology
- 12.11.1 Goodwin Biotechnology Company Information
- 12.11.2 Goodwin Biotechnology Business Overview
- 12.11.3 Goodwin Biotechnology Revenue in GMP Cell Banking Business (2020-2025)
- 12.11.4 Goodwin Biotechnology GMP Cell Banking Product Portfolio
- 12.11.5 Goodwin Biotechnology Recent Developments
- 12.12 Eurofins Scientific
- 12.12.1 Eurofins Scientific Company Information
- 12.12.2 Eurofins Scientific Business Overview
- 12.12.3 Eurofins Scientific Revenue in GMP Cell Banking Business (2020-2025)
- 12.12.4 Eurofins Scientific GMP Cell Banking Product Portfolio
- 12.12.5 Eurofins Scientific Recent Developments
- 12.13 Charles River
- 12.13.1 Charles River Company Information
- 12.13.2 Charles River Business Overview
- 12.13.3 Charles River Revenue in GMP Cell Banking Business (2020-2025)
- 12.13.4 Charles River GMP Cell Banking Product Portfolio
- 12.13.5 Charles River Recent Developments
- 12.14 Catalent
- 12.14.1 Catalent Company Information
- 12.14.2 Catalent Business Overview
- 12.14.3 Catalent Revenue in GMP Cell Banking Business (2020-2025)
- 12.14.4 Catalent GMP Cell Banking Product Portfolio
- 12.14.5 Catalent Recent Developments
- 13 Report Conclusion
- 14 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.